Shares in LiDCO Group plc (LON:LID) fell by 8% to 6.75p after saying it expects to post a loss for the 2017 financial year.
The company, which supplies hemodynamic equipment used to monitor the body's blood flow to ensure vital organs are adequately oxygenated, said a ?1.7mln investment in its expansion is likely to lead to an unspecified loss.
Total revenue is expected to rise just 1% to ?8.2mln with growth in the UK and US offset by declines in other markets. Product revenue increased 2% to ?6.9mln.
LidCo secured a major California research hospital as its new customer while its largest UK customer signed up for more monitors.
NetScientific PLC (LON:NSCI) shares rose 7% to 58.5p after saying its portfolio company, ProAxsis, had conducted the first sale of its point-of-care test for measuring neutrophil elastase.
The NEATstik test, registered with a CE mark in the second half of 2017, was sold to a research laboratory conducting a respiratory clinical trial for a pharmaceutical company.
The test utilises the company's proprietary ProteaseTag technology to allow the rapid, qualitative measurement of the active form of neutrophil elastase, an established biomarker of lung infection and inflammation.
Laura Ashley Holdings plc (LON:ALY) has warned on 2018 profits after sales over the Christmas period fell, sending shares down more than 9% to 5.5p.
The home furnishings retailer reported a 0.5% drop in like-for-like sales for the 26 weeks to December 31 and pre-tax profit halved to ?4.3mln.
The group blamed "challenging" trading conditions for the decline in sales and a slump in the pound for the lower profit.
"The board have reviewed the first half results and forecasts for the remainder of the year to 30th June 2018 and, given the continued market challenges, considers that net pre-tax profit for the year will fall below market expectations," said chairman Tan Sri Dr Khoo Kay Peng.
Neil Wilson, chief market analyst at ETX Capital, criticised the company for blaming foreign exchange rates for weaker profits. Sterling was broadly higher in 2017 and enjoyed a 10% gain against the dollar, he said.
Wilson added: "Leaving this aside, core UK like for like sales were down -0.5%. Clearly this is a challenging market and there have been a number of furniture and home retailers suffering as a result. Laura Ashley is not alone on that front."
Shares in Genel Energy PLC (LON:GENL), on the other hand, rose 5% to 119.6p after saying that it has received a payment of more than US$19mln from Kurdistan oil exports.
The company said it received US$6.08mln for its share of a US$11.05mln payment made to partners of the Taq Taq licence by the Kurdistan regional government for oil sales in November.
Genel also got US$13.68mln for its share of crude oil exports from the Tawke licence, which is operated by DNO ASA. DNO was given $54.73mln for the oil deliveries from the Kurdistan government.
Indivior PLC (LON:INDV) is in the red after the pharmaceutical company said it had set aside more cash for legal disputes.
The group has increased provisions for investigative and antitrust litigation matters by $185mln to $438mln.
Shares fell 8% to 369p.
The US Department of Justice is investigating Indivior's marketing practices. The company has also been accused of trying to delay the entry of generic versions of some of its drugs.
Oxford Biomedica PLC (LON:OXB) shares gained 8% to 11.6p after announcing a US$100mln collaboration and licence agreement with US haemophilia specialist Bioverativ Inc(NASDAQ:BIVV).
Under the deal, Oxford Biomedica will receive a US$5mln payment upfront and will also be eligible to receive various milestone payments potentially worth in excess of US$100mln and undisclosed royalties on net sales of Bioverativ's lentiviral vector haemophilia products.
Bioverativ will also fund process development and scale-up activities for its lentiviral vector haemophilia products at Oxford Biomedica.
Stadium Group plc (LON:SDM) was on the front foot after saying it has agreed to be taken over by TT Electronics plc (LON:TTG) in a deal that values the technology company at ?45.8mln.
Shares in Stadium surged 43% to 119.2p and TT Electronics was up 2% to 214.9p
Under the deal, Stadium shareholders will receive 120p for each of their shares, representing a premium of 43.7% to the closing price on Wednesday.
Stadium said it will also declare a special dividend of 2.1p per share, conditionally on completion of the takeover and in lieu of any final dividend for 2017.
The transaction will be funded from TT's existing cash resources and committed bank facilities.
"We believe that the offer from TT represents an attractive and certain value in cash today for Stadium Shareholders, reflecting the high quality of the business, its people and future prospects," said Stadium chairman Nick Brayshaw.
"The strategic fit with TT is strong and the Stadium Board believes that the combined business provides considerable scope for accelerating the development of Stadium's strategy, strengthening the foundations to grow significant shareholder value whilst continuing to broaden the opportunities for our people, our customers and our products."
Mayan Energy PLC (LON:MYN) shares rose 15% to 0.7p after saying its Gilbreath-15 well at the Forest Hill field, in Texas, has yielded 51 barrels of oil in the first 24 hours of production.
The company said the Gilbreath-19 well and the Morris-1 well continue to produce at rates consistent with their initial flow rates. It is also continuing to progress workover programmes.
On the downside, Jarvis Securities Plc (LON:JIM) shares fell 10% to 480p as the provider of retail and financial services warned it expects to take a hit from regulatory changes.
Chairman Andrew Grant urged investors to be "realistic about near-term results" as the company expects costs to increase as it makes changes to meet new regulatory requirements under the MIFID II and GDPR rules.
"In the latter half of the year, and going forward, we will be incurring higher costs on software, data feeds and higher staff numbers to ensure policies are correctly implemented and monitored as a result of additional monitoring and reporting requirements," he explained.
He said since the cost base has increased, revenues will need to rise at a higher rate to maintain the growth of the past.
The People's Operator PLC (LON:TPOP) was also under the cosh as the mobile virtual network operator reported a drop in full year revenues.
The company said average revenue per user from UK pay as you go customers fell to ?11.02 in the year through December 2017 from ?13.22 a year ago.
In the US, APRU declined to US$20.15 from US$22.09 the previous year.
The group blamed the lower revenues on discounting though its affiliate platform.
In response it has stopped all discounting through affiliate platforms, focused on improving product offerings and a departure from unprofitable plans and marketing.
Shares fell 8% to 0.10p.
Scancell Holdings Plc (LON:SCLP) has agreed another collaborative development for its Moditope anti-cancer platform. Dutch group ISA Pharmaceutical will incorporate its Amplivant technology into Modi-1, the first cancer treatment candidate being developed on the platform.
Mosman Oil And Gas Limited (LON:MSMN) has raised ?500,000 of working capital through the issue of new shares in a placing. The junior oil firm is issuing a total of 45.45mln new shares at a price of 1.1p. According to Mosman, the funds will be put towards its evaluation of new acquisition opportunities and general purposes.
InnovaDerma PLC (LON:IDP) saw its top-line grow strongly in the first half of the current financial year and the beauty and personal care products developer expects further strong growth in the second half.
Regenerative medtech Collagen Solutions PLC (LON:COS) is to go it alone in China after ending its joint venture with distributor Cre8ive. Through the JV, Collagen had agreed import licences for its tissue material, established a pipeline of potential customers and signed two agreements, but having full control from now on would mean more flexibility.
UK healthcare firm Concepta PLC (LON:CPT) has signed a marketing agreement with Chinese Wei Yi Bei Lian Information Technology Co. Ltd (BB Link) which provides free WiFi in 1,500 maternity hospitals across China. When patients connect to BB Link's free WiFi service, Concepta's landing page will be displayed with an overview of its myLotus fertility product.
NetScientific PLC (LON:NSCI), the transatlantic healthcare IP commercialisation group, said today that its portfolio company, ProAxsis, had conducted its first sale of NEATstik (R), the company's point-of-care test for measuring neutrophil elastase. The NEATstik (R) test, registered with a CE mark in the second half of 2017, was sold to a research laboratory conducting a respiratory clinical trial for a pharmaceutical company.
Pembridge Resources PLC (LON:PERE) is set to become a cash flow generating copper producer with the acquisition of Yukon-based Minto Explorations. Currently an acquisition vehicle or SPAC, Pembridge will pay US$37.5mln in cash to vendor Capstone Mining plus shares equivalent to a 9.9% stake in the enlarged company. Pembridge will then raise a further US$50mln to refinance the company and re-start exploration.
Stratex International plc (LON:STI) has teamed up with TET Madencilik to advance the Hasan??elebi and Do??ala gold projects in Turkey. The deal with TET, a private Turkish company, sees Stratex receive US$50,000 in cash and commits the new partner to spending US$1.5mln on exploration and drilling within a two-year period.
ImmuPharma PLC (LON:IMM), specialist drug discovery and development company, announced that its chairman Tim McCarthy will be presenting at an investor evening hosted by Turner Pope Investments, which acted as agent in the firm's recent ?10mln fundraise. The group said the event will be held on Monday 26 February 2018 in London, EC2 and will commence at 6pm.
RM Secured Direct Lending PLC (LON:RMDL) announced that, as at 14 February 2018, it has deployed ?25.05mmln of the proceeds of its C Share fundraising from October 2017, representing approximately 85.2% of the net proceeds of the share issue. The investment trust specialising in secured debt investments also declared an interim dividend of 2.0p per ordinary share in respect of the period from 1 October 2017 to 31 December 2017:
APQ Global Limited (LON:APQ), the AIM-listed emerging markets growth company announces that as at the close of business on 31 January 2018, the unaudited book value per ordinary share was 135.58 US cents.